Abstract
The prevalence of opioid use disorder (OUD) during pregnancy is increasing. Buprenorphine can treat OUD effectively to decrease obstetric risks. Initiation of buprenorphine, “induction”, is a high-risk time for treatment dropout and can require repeat attempts. We sought to evaluate the impact of multiple buprenorphine induction attempts on maternal and neonatal outcomes in an OUD-specific prenatal clinic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
